T
Tizona Therapeutics
Biotech & Life Sciences · South San Francisco, United States · Founded 2014
Transforming cancer treatment with first-in-class immunotherapies driven by novel scientific insights MoreLess
Tizona Therapeutics is a biotechnology startup that operates in the healthcare sector, specifically focusing on the development of innovative immunotherapies for cancer treatment. The company's primary mission is to improve the outcomes for cancer patients by translating groundbreaking scientific insights into first-in-class immunotherapies.
Tizona serves a broad range of clients, primarily patients suffering from advanced refractory or resistant malignancies. The company is currently in the clinical trial phase, with a recent initiation of a Phase 1b Expansion Study of their product TTX-080. This indicates that the company is in the process of testing its products for safety and efficacy before they can be approved for commercial use.
The business model of Tizona Therapeutics is centered around research and development. The company invests heavily in scientific research to develop novel immunotherapies. Once these therapies are developed and approved, they will be sold to healthcare providers and patients, generating revenue for the company.
In July 2020, Gilead Sciences secured an exclusive option to acquire Tizona Therapeutics for $300 million, indicating the potential value and promise of the startup's research and product pipeline. The appointment of Christine O’Brien as CEO in September 2020 further strengthens the company's leadership and strategic direction.
In summary, Tizona Therapeutics is a promising biotech startup that aims to revolutionize cancer treatment through the development of innovative immunotherapies. The company's potential for growth and success is evident in its robust research initiatives and strategic partnerships.
Keywords: Biotechnology, Cancer Treatment, Immunotherapies, Clinical Trials, Research and Development, Healthcare Sector, Advanced Refractory Malignancies, Strategic Partnerships, Gilead Sciences, Leadership.
Company overview
Tizona Therapeutics company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2014
- Headquarters
- South San Francisco, United States
- Employees
- 23
- Open positions
- None listed
- Dealroom signal
- 35.9
Valuation & funding
Tizona Therapeutics funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VCOther financing | Jul 2020 | $300M | $1.2B | Gilead Sciences | — |
| SERIES BOther financing | Mar 2016 | $43M | $172M | InterWest Partners · Lightstone Ventures · Canaan · MPM BioImpact | — |
| SERIES AOther financing | Jan 2016 | $27M | $108M | MPM BioImpact · InterWest Partners · Amgen Ventures | — |
| SPINOUTOther financing | Jan 2014 | $0 | — | University of California, San Diego | — |
Growth signals
Tizona Therapeutics website traffic
Latest recorded traffic for Tizona Therapeutics is 1.6K monthly website visits, down 30.4% over the last three months. Tizona Therapeutics's team declined 4.2% over the past year.
Comparisons
Tizona Therapeutics compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Tizona Therapeutics's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Tizona Therapeutics has talent and traffic
team presence
In the news
Latest news about Tizona Therapeutics
Recent press, funding announcements, and product moves mentioning Tizona Therapeutics — open to read from the original sources.
Market sentiment
What the market is saying about Tizona Therapeutics
An AI-synthesized read of the highest-engagement posts about Tizona Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Tizona Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.